Understand the source comparison
Comparative Analysis: LL-37 vs Other Host Defense Peptides
When we compare top LL-37 studies against research on other human antimicrobial peptides. Defensins, cathelicidins, histatins. LL-37 stands out for mechanistic versatility but also for formulation challenges. Human β-defensin-3 (hBD-3) shows stronger direct ba
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- When we compare top LL-37 studies against research on other human antimicrobial peptides. Defensins, cathelicidins, histatins. LL-37 stands out for mechanistic versatility but also for formulation challenges. Human β-defensin-3 (hBD-3) shows stronger direct bactericidal activity at equivalent molar concentrations, but it lacks LL-37's receptor-mediated immunomodulation. A 2013 head-to-head comparison in Journal of Biological Chemistry tested both peptides against S. aureus biofilms. hBD-3 achieved 90% bacterial reduction at 10 µg/mL versus 60% for LL-37 at the same concentration. But LL-37-treated biofilms showed 3× higher dispersal rates (bacteria leaving the biofilm and returning to planktonic growth), making them vulnerable to secondary antibiotic treatment. The defensin killed more bacteria; the cathelicidin made the survivors easier to kill with conventional drugs.
- LL-37's structural flexibility. It transitions between α-helical and random coil conformations depending on pH and lipid environment. Gives it functional range that more rigid peptides lack, but it also makes stability prediction nearly impossible without empirical testing. Studies using circular dichroism spectroscopy show LL-37 loses helical structure below pH 5.5, which matters in acidic wound environments. A 2019 study in Biomaterials tested LL-37 formulated in pH-buffered hydrogels versus unbuffered saline. The buffered formulation maintained 85% antimicrobial activity after 7 days at 37°C; the unbuffered version dropped to 22% activity under identical conditions. That pH sensitivity doesn't appear in most other antimicrobial peptide families and represents a significant formulation barrier for therapeutic development.
- LL-37
- 8–16
- Accelerates closure 2–3× (EGFR-dependent)
- Suppresses IL-6/TNF-α, upregulates IL-10 in presence of LPS
- 22% activity retained (unbuffered), 85% (pH 7.4 buffer)
- Multifunctional but formulation-sensitive. Requires pH control and precise dosing to avoid cytotoxicity
- hBD-3
- 2–8
- Minimal direct effect on keratinocyte migration
- Primarily pro-inflammatory (IL-8 induction)
- >90% activity retained (unbuffered)
- Superior bactericidal potency but lacks immunomodulatory range. Best for direct pathogen clearance
- Cathelicidin-BF (bovine)
- 4–12
- Moderate angiogenesis induction
- Weak cytokine response
- 60% activity retained (unbuffered)
- Comparable antimicrobial spectrum to LL-37 but weaker immune signaling. Useful when stability matters more than versatility